Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -6.1%
- Operating Margin Trend -228.50 pp/yr
VIR
Vir Biotechnology, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 22.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
16
- 5yr Avg ROE -13.9%
- 5yr Share-Count CAGR 0.9%
Growth Quality
Weight: 35%
F
13
- 5yr Revenue CAGR -50.0%
- 5yr EPS CAGR -3.3%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
D+
41
- 5yr FCF Margin -405.2%
- 5yr FCF/NI Conversion 1.48x
Balance Sheet
Weight: 10%
D
38
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 1.60
Stability
Weight: 5%
B-
65
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 3
- Negative-Revenue Years (5) 3/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 added.
- Holders
- 2
- Avg Δ position
- +1219.8%
- New buys
- 0
- Full exits
- 0